• Medroxyprogesterone Acetate: Lipid Metabolism and Decidualiz

  2026-05-24

  Explore how Medroxyprogesterone acetate (MPA) advances research into endometrial lipid metabolism and decidualization. Gain a unique, mechanistic perspective on MPA's role in hormone signaling and experimental design.

• Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Appli

  2026-05-23

  The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) addresses the risk of protein degradation during extraction and analysis by inhibiting a broad range of cellular proteases. Its EDTA-free formulation makes it suitable for workflows requiring preservation of divalent cations, but it should not be used if metalloprotease inhibition is essential. This guide outlines effective application and troubleshooting strategies for research workflows.

• Losartan in Inflammation-Driven Vascular and Renal Research

  2026-05-22

  Explore how Losartan, a selective angiotensin II receptor antagonist, advances research into inflammation-mediated vascular and renal pathologies. This article uniquely integrates recent mechanistic insights and comparative assay guidance for hypertension research.

• AMPK-PINK1/Parkin Mitophagy Regulates Inflammation in Diabet

  2026-05-22

  This study elucidates the regulatory role of AMPK in orchestrating the interplay between PINK1/Parkin-mediated mitophagy and NLRP3-driven inflammation in periodontal ligament fibroblasts under mechanical loading—particularly within diabetic microenvironments. The findings reveal that targeted AMPK activation restores mitophagic flux and suppresses pro-inflammatory cascades, offering a mechanistic foundation for future therapeutic strategies in diabetic periodontal disease.

• Mecamylamine Hydrochloride: Dissecting nAChR Pathways in Tra

  2026-05-21

  This article illuminates how mecamylamine hydrochloride empowers translational researchers to interrogate nicotinic acetylcholine receptor (nAChR) function across the gut-brain axis and neuropsychiatric disorder models. Blending mechanistic insight, protocol guidance, and strategic recommendations, it bridges recent breakthroughs in cholinergic signaling with practical assay design, highlighting opportunities and caveats for innovative translational workflows.

• Dual OXPHOS Disruption: LRPPRC Inhibition Plus Dasatinib in

  2026-05-21

  This study reveals that inhibiting LRPPRC, a mitochondrial RNA-binding protein, in combination with dasatinib, a multi-kinase inhibitor, produces a synergistic anti-tumor effect by coordinately disrupting both mitochondrial and nuclear-encoded oxidative phosphorylation (OXPHOS) pathways. The findings provide a mechanistic rationale for tailored combination therapy in cancers reliant on OXPHOS metabolism.

• Bobcat339: Unlocking TET Inhibitor Power in Epigenetics Rese

  2026-05-20

  Bobcat339 enables precise modulation of DNA methylation and gene transcription, empowering researchers to dissect epigenetic regulatory mechanisms in osteogenesis and beyond. This guide delivers actionable workflows, troubleshooting strategies, and experimental context, bridging reference breakthroughs with hands-on application.

• Berberrubine Inhibits IL-8 and MCP-1 via NF-κB in Retinal Ce

  2026-05-20

  This study demonstrates that berberrubine, a protoberberine alkaloid, dose-dependently inhibits IL-8 and MCP-1 expression in human retinal pigment epithelial cells stimulated with pro-inflammatory cytokines. The findings highlight berberrubine's mechanism involving suppression of NF-κB translocation, offering insights for therapeutic modulation of retinal inflammation.

• G-15 Antagonist: Advanced Insights for GPR30 Signaling Resea

  2026-05-19

  Explore the mechanistic depth of G-15, a selective G protein-coupled estrogen receptor antagonist, and its pivotal role in estrogen signaling research. This article delivers novel perspectives on assay design and translational applications, setting it apart from existing resources.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Technical Use Guide

  2026-05-19

  The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody provides a reliable solution for sensitive fluorescent detection of goat IgG in immunocytochemistry, immunohistochemistry, flow cytometry, and ELISA workflows. It is not suitable for detection of non-goat primaries or outside established immunodetection protocols. Proper use minimizes background and maximizes signal amplification in fluorescence-based assays.

• Novobiocin Sodium: Beyond Bacterial Inhibition to Antiparasi

  2026-05-18

  Explore Novobiocin Sodium, a potent aminocoumarin antibiotic, in the context of antiparasitic research. This article uniquely dissects its mechanistic action, cross-domain applications, and the latest in vitro insights, setting a new benchmark for advanced DNA damage and metabolic pathway studies.

• EZ Cap™ Cre mRNA (m1Ψ): Applied Gene Editing Workflows & Tro

  2026-05-18

  EZ Cap™ Cre mRNA (m1Ψ) from APExBIO sets a new standard for high-efficiency, low-immunogenicity Cre recombinase delivery in gene editing and functional studies. This article translates recent advances in extrahepatic mRNA delivery into actionable lab workflows, optimization tactics, and troubleshooting strategies for researchers seeking robust, reproducible results.

• Estradiol, ER Stress, and GPR30 in CD4+ T Cell Recovery Post

  2026-05-17

  This study uncovers how estradiol-mediated inhibition of endoplasmic reticulum stress restores splenic CD4+ T lymphocyte function after hemorrhagic shock. By dissecting the signaling roles of ERα and GPR30, but not ERβ, it provides mechanistic insight into estrogen’s immunomodulatory effects and identifies specific receptor targets for future research.

• ATG4B Nuclear Translocation Links Energy Deficiency to DNA R

  2026-05-16

  This study uncovers a mechanistic link between cellular energy deficiency and impaired DNA repair in acute myeloid leukemia (AML). By demonstrating that energy stress drives ATG4B nuclear translocation, which in turn inhibits PRMT1-mediated DNA repair, the research identifies actionable molecular targets for improving genomic stability in leukemia models.

• Ademetionine (SAM): New Frontiers in Neuroepigenetics

  2026-05-15

  This thought-leadership article explores the expanding translational landscape for S-Adenosylmethionine (SAM, Ademetionine) as a methyl donor in neuroepigenetic research and clinical neuroscience. By connecting mechanistic depth with protocol guidance and translational strategy, the piece differentiates itself from standard product overviews, providing actionable insights for researchers navigating methylation assays, central nervous system disorder models, and emerging clinical applications.

450 records 17/30 page Previous Next First page 上5页 1617181920 下5页 Last page